PFA
AUPH icon

Professional Financial Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Professional Financial Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-260
Closed -$2K – 100
2022
Q3 		$2K Hold
260
– – ﹤0.01% 420
2022
Q2 		$3K Hold
260
– – ﹤0.01% 400
2022
Q1 		$3K Hold
260
– – ﹤0.01% 406
2021
Q4 		$6K Hold
260
– – ﹤0.01% 354
2021
Q3 		$6K Hold
260
– – ﹤0.01% 299
2021
Q2 		$3K Hold
260
– – ﹤0.01% 348
2021
Q1 		$3K Hold
260
– – ﹤0.01% 307
2020
Q4 		$4K Hold
260
– – ﹤0.01% 298
2020
Q3 		$4K Buy
+260
New +$3.77K ﹤0.01% 281

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Professional Financial Advisors's AUPH Position: Q4 2022 in Review

Professional Financial Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 260 shares — an estimated $2K sold.

Professional Financial Advisors first reported a position in AUPH in Q3 2020 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • Professional Financial Advisors reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Professional Financial Advisors sold 260 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • Professional Financial Advisors first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • Professional Financial Advisors's Aurinia Pharmaceuticals position peaked at $6K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Professional Financial Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.